Gerber Kawasaki Wealth & Investment Management Exact Sciences Corp Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $435 - $604	-6 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $541 - $744	6 New	6 $0

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.06 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$941 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$851 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$717 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$397 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account